100 likes | 106 Views
Intraoperative neuromonitoring (IONM) is an important procedure that helps to assess the functional integrity of the brain, brain stem, spinal cord, or peripheral nerves during and after complex surgical procedures. IONM reduces the risk of deficits such as muscle weakness, paralysis, hearing loss, and other normal body functions. IONM provides immediate feedback and warning to the surgeon for the prevention of permanent nerve injury because of post-surgical damage.
E N D
Intraoperative Neuromonitoring Market |2022-2029 Intraoperative Neuromonitoring Market is segmented By Modality Segment (Evoked Potential (EP) Market, Electromyography (EMG) Market, Electroencephalogram (EEG) Market), By Service Segment (In- source IONM and Out-source IONM), By Application (Neurological Surgeries, Orthopedic Surgeries, Surgeries, Other Surgeries), and By Region (North America, Latin America, Europe, Asia Pacific, Middle East, and Africa) – Share, Size, Outlook, and Opportunity Analysis, 2022-2029. ENT Surgeries, Cardiovascular Copy Right: DataM Intelligence 4Market Research info@datamintelligence.com
Intraoperative Neuromonitoring Market |2022-2029 DataM Intelligence 4market a leading market research firm, has announced the release of its latest report on the "Intraoperative Neuromonitoring Market”. The report provides an analysis of the market dynamics and trends that are expected to shape its future growth trajectory. The global Intraoperative Neuromonitoring market was worth USD 3.02 billion in 2021 and is predicted to increase at a compound annual growth rate (CAGR) of 6.53% between 2022 and 2029. The increased emphasis on patient safety during challenging surgical operations, as well as the rising frequency of chronic illnesses such as stroke, epilepsy, Alzheimer's disease, and Parkinson's disease, can be linked to the market's expansion. According to the WHO, neurological illnesses impact hundreds of millions of people globally. Every year, 15 million people worldwide suffer from a brain stroke. This has contributed to the market's expansion. Browse Fullreport@https://www.datamintelligence.com/research-report/intraoperative- neuromonitoring-market Copy Right: DataM Intelligence 4Market Research info@datamintelligence.com
Intraoperative Neuromonitoring Market |2022-2029 COVID-19 Impact on the Intraoperative Neuromonitoring Market The COVID-19 pandemic will have various consequences on the intraoperative neuromonitoring (IONM) industry. Hospitals in the United States and throughout the world have postponed or delayed elective procedures to varied degrees in order to allocate and divert medical resources and capacity to the COVID-19 reaction. Manufacturers have finding it difficult to service their surgeon clients since certain hospitals have limited or modified access requirements. As a result, they anticipate to see a fall in procedure volume in 2020, stifling growth. . Browse Free Sample Report @ https://www.datamintelligence.com/download- sample/intraoperative-neuromonitoring-market Copy Right: DataM Intelligence 4Market Research info@datamintelligence.com
Intraoperative Neuromonitoring Market |2022-2029 Intraoperative Neuromonitoring Market Segmentation: By Modality Segment: • Evoked Potential (EP) • Electromyography (EMG) • Electroencephalogram (EEG) By Service Segment: • In-source IONM • Out-source IONM By Application: • Neurological Surgeries • Orthopedic Surgeries • ENT Surgeries • Cardiovascular Surgeries • Other Surgeries Copy Right: DataM Intelligence 4Market Research info@datamintelligence.com
Intraoperative Neuromonitoring Market |2022-2029 Segment Insights: In 2021, the insourced type led the market, accounting for more than 55.19% of worldwide sales. This is due to an increase in procedure frequency and the necessity that vital data be maintained throughout each surgery. Hospitals are implementing IONM and educating technicians to supervise operations performed by neurologists and physiologists. There are no set criteria for using neuromodulation devices, but the practice is projected to become more widespread as demand and usage grow. Regional Insights: North America led the market, accounting for more than 49.30% of global revenue in 2021. The advantageous reimbursement picture, as well as the growing instances of neurological illnesses, are important contributions to this domination. According to the National Institute of Health, approximately 795,000 people in the United States experience a stroke each year, resulting in 137,000 fatalities. Furthermore, according to the Migraine Research Foundation, about 35 million people in the United States will suffer from migraine headaches by 2020. Furthermore, roughly 43% of women and 18% of men in the country are predicted to suffer from migraines. As a result, rising rates of neurological illnesses such TBI, migraine, and stroke are expected to fuel market expansion in this nation. Copy Right: DataM Intelligence 4Market Research info@datamintelligence.com
Intraoperative Neuromonitoring Market |2022-2029 Intraoperative Neuromonitoring Market Intraoperative Neuromonitoring Market By End User By Service By Modality By Application • Pharmaceutical & Biotechnology Companies Contract Research Organizations (CROs) Academic & Research Institutions Others • • • • • • • In-Source IONM Evoked Potential Electromyography Electroencephalogram Neurological Surgeries Orthopedic Surgeries ENT Surgeries • Out-Source IONM • • • Copy Right: DataM Intelligence 4Market Research info@datamintelligence.com
Intraoperative Neuromonitoring Market |2022-2029 Major Countries Focused: Major Countries Focused: Geographical Classification Geographical Classification • • • • • North America Europe South America Asia Pacific Middle East and Africa • • • • • • • • • • • United States Canada Brazil Spain Italy United Kingdom South Korea Russia China Japan Rest of the Countries Copy Right: DataM Intelligence 4Market Research info@datamintelligence.com
Intraoperative Neuromonitoring Market |2022-2029 Some of the Major Players Covered in the Market: • • • • • • • • • • SpecialtyCare Natus Medical Incorporated NuVasive Inc Medtronic Plc Inomed Medizintechnik GmbH Accurate Monitoring Cadwell Industries Inc. Computational Diagnostics Inc. Nihon Kohden Corp. Medsurant Health LLC. Copy Right: DataM Intelligence 4Market Research info@datamintelligence.com
|| About Us || DataM Intelligence was incorporated in the early weeks of 2017 as a Market Research and Consulting firm with just two people on board. Within a span of less than a year, we have secured more than 100 unique customers from established organizations all over the world. We monitor and analyze the market by dissecting various market influencers, competitive intensity, innovations, trends, and emerging products. This aids us in providing a detailed scenario of the present and future of the market. Copy Right: DataM Intelligence 4Market Research info@datamintelligence.com
|| Contact Us || Contact Us: Sai Kiran DataM Intelligence 4Market Research LLP +91 877–441–4866 info@datamintelligence.com Follow Us on Copy Right: DataM Intelligence 4Market Research info@datamintelligence.com